Company / EPS (Basic)
Harmony Biosciences Holdings, Inc. EPS (Basic) History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
$2.17
FY2025
5-year range
-$24.07 / $3.07
FY2021-FY2025
Trend
-29.3%
vs FY2024
Sector context
#24 of 208
Health Care
What the data says
Harmony Biosciences Holdings, Inc.'s eps (basic) of $2.17 is higher than 88% of companies in the Health Care sector (FY2025). Improved from $0.60 to $2.17 over the past 2 years.
Based on SEC 10-K filings.
2.17 in FY2025. Top quartile in the Health Care sector.
Improved from $0.60 to $2.17 over the past 2 years.
Health Care sector context is included.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 208This company $2.17 Sector average -$0.96
▼
+325.3% above sector average
Key checks
Key Insights
- In FY2025, eps (basic) decreased 29.3% year-over-year.
- Ranks #24 out of 208 companies in the Health Care sector.
- Peak eps (basic) was recorded in FY2024.
- Lowest eps (basic) in the period was in FY2021.
Company context
Key Data Points
- Strong profit margin: 20.4%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.17 | -29.3% |
| FY2024 | $3.07 | +411.7% |
| FY2023 | $0.60 | +124.2% |
| FY2022 | -$2.48 | +89.7% |
| FY2021 | -$24.07 | +0.0% |
| FY2020 | -$24.07 | +0.0% |
| FY2019 | -$24.07 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026